BDRX

Biodexa Pharmaceuticals
BDRX

10 hedge funds and large institutions have $136K invested in Biodexa Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

more capital invested

Capital invested by funds: $ → $

more funds holding

Funds holding: →

less ownership

Funds ownership: →

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
10
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$32K
2
+$30K
3
+$27K
4
TSS
Two Sigma Securities
New York
+$18.4K
5
GSC
Ground Swell Capital
South Carolina
+$11.7K

Top Sellers

1
-$6.1K
2
-$4.61K
3
-$26
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$32K
2
$30K
3
$27K
4
$18.4K
5
$11.7K
6
$8.96K
7
$3.49K
8
$2.42K
9
$896
10
$769
11
$14
12
$11
13
$7